Fundraising is picking up among crypto venture funds after two dismal years, as investors hope to profit from the friendly ...

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of InflaRx N.V. (NasdaqGS:IFRX) with a Overweight recommendation. Analyst Price Forecast Suggests 536.20% Upside As of ...

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of BioCryst Pharmaceuticals (NasdaqGS:BCRX) with a Overweight recommendation. Analyst Price Forecast Suggests 86.43% ...

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Astria Therapeutics (NasdaqGM:ATXS) with a Overweight recommendation. Analyst Price Forecast Suggests 428.96% Upside ...

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of BioCryst Pharmaceuticals (BMV:BCRX) with a Overweight recommendation. Avoro Capital Advisors holds 11,865K shares ...

Fintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 239.41% Upside As ...

Cantor Fitzgerald analyst Steve Seedhouse assumed coverage of ProQR Therapeutics (PRQR) with an Overweight rating and $8 price target ProQR is a leader in RNA editing and the initial biomarker ...